Nicole Concin

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma

Nicole Concin, Xavier Matías‐Guiu, Ignace Vergote et al. · International Journal of Gynecological Cancer · 2020 · 1.8K citations · Full text

Endocrine-related Cancer, Medicine, Cancer Management +7

ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

Nicoletta Colombo, Cristiana Sessa, Andreas du Bois et al. · Annals of Oncology · 2019 · 1.1K citations · Full text

Borderline Tumours, Tumoral Pathology, Medicine +9

<scp>FIGO</scp> staging of endometrial cancer: 2023

Jonathan S. Berek, Xavier Matías‐Guiu, Carien L. Creutzberg et al. · International Journal of Gynecology & Obstetrics · 2023 · 811 citations · Full text

Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study

Robert L. Coleman, Domenica Lorusso, Christine Gennigens et al. · The Lancet Oncology · 2021 · 367 citations

Tisotumab Vedotin, Cervical Cancer, Metastatic Cervical Cancer +8

ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease

Jonathan A. Ledermann, Xavier Matías‐Guiu, Frédéric Amant et al. · Annals of Oncology · 2024 · 223 citations · Full text